Essential Tips for First-Time Medtech CEOs: Interview with Dan Rose, CEO of LimFlow

I recently had the opportunity to interview Dan Rose, CEO of the
French-based medtech company LimFlow. Founded in 2012, LimFlow
transformed the peripheral vasculature space by providing a
lifesaving option for end-stage critical limb-threatening
ischemia (CLTI) patients facing amputation. LimFlow is designed
to restore blood flow to the ischemic foot via deep vein
arterialization, thereby preventing major amputation, resolving
pain, and promoting wound healing. 


Prior to assuming the role of CEO at LimFlow in August 2016, Dan
had more than 16 years of leadership experience in the medical
device and venture capital/startup sectors. Most recently, he was
VP and General Manager EMEA for Direct Flow Medical, and VP of
Commercial Operations and a Member of the Board at Sequana
Medical, a Swiss medical device company. 


Norbert Juist, an executive recruiter who specializes in medical
device sales and marketing, also joined me for this interview
with Dan Rose. Norbert brings a unique perspective to this
discussion, having worked as a sales rep and consultant in
medtech for nearly 20 years prior to transitioning to executive
recruiting.


Here are a few of the topics we discuss in this episode:


How LimFlow used a concept that’s been in existence since
1912 and transformed it into a modern therapy that
multidisciplinary clinicians can reproduce.

How Med Start played an instrumental role in the launch and
ultimate success of LimFlow.

Why it’s essential to find a physician champion willing to
invest time and energy in your tech.

Overcoming the challenges presented by an ever-evolving MDR
landscape, both in the EU and US.

Key factors you can’t ignore if you want to succeed as a
first-time CEO.

Why investing in independent market research is well worth
the cost.

Why the FDA Breakthrough Devices Program has been a game
changer in the US.



See more...